A detailed history of Fil LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Fil LTD holds 8,889 shares of MRNA stock, worth $327,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,889
Previous 130 6737.69%
Holding current value
$327,559
Previous $15,000 3860.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $557,422 - $1.1 Million
8,759 Added 6737.69%
8,889 $594,000
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $13,157 - $21,659
130 New
130 $15,000
Q2 2019

Aug 13, 2019

SELL
$13.7 - $28.34 $22.2 Million - $45.8 Million
-1,616,898 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$14.45 - $23.7 $7.81 Million - $12.8 Million
540,754 Added 50.25%
1,616,898 $32.9 Million
Q4 2018

Feb 13, 2019

BUY
$13.52 - $18.8 $14.5 Million - $20.2 Million
1,076,144 New
1,076,144 $16.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.